AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
What Does Vanguard’s Stake Reduction Signal for Altimmune (NASDAQ:ALT)?
April 14, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,Vanguard Group Inc. decreased its stake in Altimmune during the recent quarter.,Wellington Management Group and Charles Schwab Investment Management made position increases.,Altimmune remains focused on clinical-stage development in obesit...
How Are Funds Rebalancing Around Catalyst Pharmaceuticals (NASDAQ:CPRX)?
April 14, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,Geode Capital Management LLC maintained a sizable position in Catalyst Pharmaceuticals.,Multiple institutions increased their holdings during the most recent quarter.,The company is engaged in therapies targeting rare neuromuscular and neu...
Is Institutional Interest in ACADIA Pharmaceuticals (NASDAQ:ACAD) Growing?
April 14, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,Geode Capital Management LLC marginally increased its stake in ACADIA Pharmaceuticals during the fourth quarter.,Institutional holders now account for the vast majority of the company’s equity.,ACADIA’s product line continues to focus on t...
Is Supernus Pharmaceuticals (NASDAQ:SUPN) a Core Pick in the CNS Drug Sector?
April 14, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,Geode Capital Management LLC expanded its holdings in Supernus Pharmaceuticals during the fourth quarter.,Additional institutions reported significant stake increases in the specialty pharmaceutical firm.,The company remains focused on tre...
Is Johnson & Johnson (NYSE:JNJ) Positioned for Growth in the Healthcare Sector?
April 13, 2025 07:40 PM AEST| By Team Kalkine MediaHighlights,Johnson & Johnson has recently seen a modest increase in share price.,The healthcare sector remains an area of strong performance for the company.,Analysts have varied perspectives on Johnson & Johnson’s stock.,Healthcare Sector Overview,T...
Alliancebernstein L.P. Acquires Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
April 13, 2025 06:44 PM AEST| By Team Kalkine MediaHighlights,Alliancebernstein L.P. significantly increased its holdings in Crinetics Pharmaceuticals, reflecting growing interest in the company.,Wellington Management Group LLP also boosted its stake in Crinetics, marking a trend of heightened instit...
Alliancebernstein L.P. Acquires Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
April 13, 2025 06:44 PM AEST| By Team Kalkine MediaHighlights,Beam Therapeutics,(NASDAQ:BEAM),sees expanded interest from major financial entities and fund managers.,Leadership within the company has executed stock transactions, slightly adjusting insider holdings.,Biotech development efforts continu...
What Drives Institutional Shifts in Biotechnology Companies Like Replimune Group?
April 13, 2025 06:44 PM AEST| By Team Kalkine MediaHighlights,Alliancebernstein L.P. decreased its holdings in Replimune Group,(NASDAQ:REPL),during the fourth quarter.,Several institutions initiated new positions in the biotechnology company during recent quarters.,Replimune Group continues to operat...
Nuvalent, Inc. Sees Uptick in Institutional Activity Amid Strategic Advancements (NASDAQ:NUVL)
April 11, 2025 05:29 PM AEST| By Team Kalkine MediaHighlights,Commonwealth Equity Services expanded its position in Nuvalent during the final quarter.,Multiple firms increased stakes in Nuvalent, reflecting ongoing market engagement.,Share movements and executive transactions indicate dynamic trading...
Institutional Movements Reshape SPDR S&P Pharmaceuticals ETF Positioning (NYSEARCA:XPH)
April 11, 2025 05:28 PM AEST| By Team Kalkine MediaHighlights,Commonwealth Equity Services LLC reduced its shareholding in the SPDR S&P Pharmaceuticals ETF during the recent quarter,Notable activity observed from financial entities including SVB Wealth LLC and US Bancorp DE,The ETF opened at a lower...
AbbVie’s Market Position: Financial Shifts and Strategic Shareholder Activity
April 11, 2025 05:28 PM AEST| By Team Kalkine MediaHighlights,Market sentiment surrounding AbbVie (NYSE:ABBV) has shifted following rating changes and price objective adjustments.,Executive share disposals have drawn attention amid changing stock trends and valuation metrics.,Institutional interest i...
How Did Evolus (NASDAQ:EOLS) Attract Fresh Institutional Attention in Q4?
April 11, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,Corebridge Financial reduced its holdings in Evolus during the fourth quarter.,Other institutions, including Charles Schwab and Lord Abbett, significantly increased their positions.,Evolus operates in the performance beauty sector with a f...
Is Cullinan Therapeutics (NASDAQ:CGEM) Gaining Ground in the Biopharma Sector?
April 11, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,Corebridge Financial Inc. reduced its position in Cullinan Therapeutics during the fourth quarter.,State Street Corp and Geode Capital Management expanded their stakes in the third quarter.,Cullinan Therapeutics is advancing oncology progr...
Is Pacific Biosciences (NASDAQ:PACB) at the Center of Biotech Sector Changes?
April 11, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,Commonwealth Equity Services LLC reduced its holdings in Pacific Biosciences during the fourth quarter.,Contrasting activity seen as FMR LLC and Charles Schwab Investment Management increased their positions.,Pacific Biosciences remains fo...
How Is Prothena (NASDAQ:PRTA) Navigating the Clinical Development Space?
April 11, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,Corebridge Financial decreased its stake in Prothena during the fourth quarter.,Major institutions like Vanguard Group and American Century Companies adjusted their positions.,Prothena remains focused on advancing therapies for neurologica...
Is Orthofix Medical (NASDAQ:OFIX) Navigating a New Institutional Landscape?
April 11, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,Corebridge Financial Inc. has adjusted its position in Orthofix Medical Inc.,The company continues to expand its orthopedic and spine innovation footprint across major global markets.,Orthofix operates within the medical device sector with...
Is LENZ Therapeutics (NASDAQ:LENZ) Becoming a Core Focus in Biopharma Allocations?
April 11, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,American Century Companies Inc. expanded its position in LENZ Therapeutics.,A variety of other institutions increased their stakes in the company.,More than half of LENZ Therapeutics shares are now held by institutional participants,LENZ T...
Is Keros Therapeutics (NASDAQ:KROS) Experiencing a Shift in Institutional Engagement?
April 11, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,Significant stake increases from institutional firms, including new entries by KLP Kapitalforvaltning AS and SG Americas Securities LLC.,Volatility in share performance tied to clinical advancements and fiscal developments.,Keros Therapeut...
Is Spyre Therapeutics (NASDAQ:SYRE) Attracting Attention Through Clinical Innovation?
April 11, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,Vanguard Group Inc. significantly raised its equity position in Spyre Therapeutics in recent quarters.,Additional institutional firms, including State Street Corp and Geode Capital Management LLC, also expanded their stakes.,The company co...
How Is Institutional Interest Evolving in SI-BONE (NASDAQ:SIBN)?
April 11, 2025 05:00 PM AEST| By Team Kalkine MediaHighlights,Corebridge Financial Inc. reduced its position in SI-BONE during the fourth quarter.,American Century Companies Inc. and Harbor Capital Advisors Inc. significantly increased their stakes.,Institutional ownership of SI-BONE remains high, ex...
